Ulland Investment Advisors’s AdvisorShares Pure US Cannabis ETF MSOS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q1
Sell
-7,000
Closed -$49K 244
2023
Q4
$49K Hold
7,000
0.05% 107
2023
Q3
$56K Hold
7,000
0.06% 98
2023
Q2
$39K Sell
7,000
-13,175
-65% -$72.3K 0.04% 111
2023
Q1
$115K Buy
20,175
+75
+0.4% +$496 0.14% 65
2022
Q4
$140K Buy
20,100
+1,700
+9% +$17.5K 0.17% 61
2022
Q3
$164K Buy
18,400
+5,650
+44% +$65.2K 0.18% 60
2022
Q2
$132K Sell
12,750
-7,175
-36% -$107K 0.14% 64
2022
Q1
$416K Buy
19,925
+580
+3% +$12.7K 0.31% 46
2021
Q4
$495K Buy
+19,345
New +$534K 0.32% 48

Other funds holding MSOS

Ulland Investment Advisors's MSOS Position: Q1 2024 in Review

Ulland Investment Advisors sold out of AdvisorShares Pure US Cannabis ETF (MSOS) in Q1 2024, closing a stake of 7,000 shares — an estimated $49K sold.

Ulland Investment Advisors first reported a position in MSOS in Q4 2021 and held it in 9 quarters. The position peaked at $495K in Q4 2021. 187 funds tracked by Wall St. Rank hold MSOS as of Q1 2024.

  • Ulland Investment Advisors reported no remaining AdvisorShares Pure US Cannabis ETF position as of Q1 2024 after selling out during the quarter.
  • Ulland Investment Advisors sold 7,000 AdvisorShares Pure US Cannabis ETF shares in Q1 2024, an estimated $49K.
  • Ulland Investment Advisors first reported a position in AdvisorShares Pure US Cannabis ETF in Q4 2021 and held it in 9 quarters.
  • Ulland Investment Advisors's AdvisorShares Pure US Cannabis ETF position peaked at $495K in Q4 2021.
  • 187 funds tracked by Wall St. Rank held AdvisorShares Pure US Cannabis ETF as of Q1 2024.

Based on Ulland Investment Advisors's 13F filing for Q1 2024, filed 25 Apr 2024.